A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN

Myeloid neoplasm (MPN) clones can evolve from acute myeloid leukemia to gain dominance with isocitrate dehydrogenase inhibition. Pro-differentiation agents such as ivosidenib can unmask MPN sequelae.

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Xiao, Wenbin, Miles, Linde A., Bowman, Robert L., Durani, Vidushi, Tian, Helen S., DelGaudio, Nicole L., Mishra, Tanmay, Zhu, Menglei, Zhang, Yanming, Stump, Sarah E., Tallman, Martin S., Levine, Ross L., Cai, Sheng F.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2020
Fag:
Exceptional Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724900/
https://ncbi.nlm.nih.gov/pubmed/33284943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003326
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker